164 related articles for article (PubMed ID: 12944527)
21. Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors.
van der Giet M; Jankowski J; Schlüter H; Zidek W; Tepel M
J Hypertens; 1998 Dec; 16(12 Pt 2):1939-43. PubMed ID: 9886880
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a diadenosine tetraphosphate-receptor distinct from the ATP-purinoceptor in human tracheal gland cells.
Saleh A; Picher M; Kammouni W; Figarella C; Merten MD
Eur J Pharmacol; 1999 Nov; 384(1):91-8. PubMed ID: 10611424
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
24. Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
Wu KJ; Hung TW; Wang YS; Chen YH; Bae EK; Yu SJ
Sci Rep; 2023 May; 13(1):8148. PubMed ID: 37208379
[TBL] [Abstract][Full Text] [Related]
25. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
[TBL] [Abstract][Full Text] [Related]
26. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
27. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
28. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra.
He Y; Lee T; Leong SK
Brain Res; 2000 Mar; 858(1):163-6. PubMed ID: 10700609
[TBL] [Abstract][Full Text] [Related]
29. Diadenosine tetraphosphate (AP4A) mimics cardioprotective effect of ischemic preconditioning in the rat heart: contribution of KATP channel and PKC.
Ahmet I; Sawa Y; Nishimura M; Ichikawa H; Matsuda H
Basic Res Cardiol; 2000 Jun; 95(3):235-42. PubMed ID: 10879625
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
[TBL] [Abstract][Full Text] [Related]
31. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of dinucleoside polyphosphates catalyzed by firefly luciferase.
Sillero MA; Guranowski A; Sillero A
Eur J Biochem; 1991 Dec; 202(2):507-13. PubMed ID: 1761051
[TBL] [Abstract][Full Text] [Related]
33. Diadenosine polyphosphates inhibit adenosine kinase activity but decrease levels of endogenous adenosine in rat brain.
Delaney SM; Blackburn GM; Geiger JD
Eur J Pharmacol; 1997 Jul; 332(1):35-42. PubMed ID: 9298923
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex.
Qi J; Hong ZY; Xin H; Zhu YZ
Biol Pharm Bull; 2010; 33(12):1958-64. PubMed ID: 21139233
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney.
van der Giet M; Khattab M; Börgel J; Schlüter H; Zidek W
Br J Pharmacol; 1997 Apr; 120(8):1453-60. PubMed ID: 9113365
[TBL] [Abstract][Full Text] [Related]
36. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.
Harvey BK; Mark A; Chou J; Chen GJ; Hoffer BJ; Wang Y
Brain Res; 2004 Oct; 1022(1-2):88-95. PubMed ID: 15353217
[TBL] [Abstract][Full Text] [Related]
37. The interaction of diadenosine polyphosphates with P2x-receptors in the guinea-pig isolated vas deferens.
Westfall TD; McIntyre CA; Obeid S; Bowes J; Kennedy C; Sneddon P
Br J Pharmacol; 1997 May; 121(1):57-62. PubMed ID: 9146887
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the binding of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) to rat liver cell membranes.
Edgecombe M; McLennan AG; Fisher MJ
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):687-93. PubMed ID: 8670086
[TBL] [Abstract][Full Text] [Related]
39. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat.
Noto T; Ishiye M; Furuich Y; Keida Y; Katsuta K; Moriguchi A; Matsuoka N; Aramori I; Goto T; Yanagihara T
Brain Res Mol Brain Res; 2004 Sep; 128(1):30-8. PubMed ID: 15337315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
